The female segment held the largest market share in 2021.Moreover, the same segment is anticipated to register the highest CAGR during 2021-2028

2022-05-29 07:18:24 By : Mr. Jim Hu

The silicone based catheters market is projected to reach US$ 240. 905 million by 2028 from US$ 150. 866 million in 2021; it is expected to grow at a CAGR of 6. 9% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the market growth.

New York, April 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Silicone Based Catheters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application, Usage, Tip, Product Type, Type, and End User" - https://www.reportlinker.com/p06270040/?utm_source=GNW The silicone based catheters market growth is attributed to the increasing prevalence of urinary incontinence and benign prostatic hyperplasia (BPH) and the rising number of surgical procedures. However, the increasing chances of bacterial infection due to prolonged use of catheters hamper the growth of the market. Urinary incontinence (UI) is a major problem associated with many medical conditions.Urinary incontinence results from occasional or mild leaking to uncontrolled chronic urination. UI is the most common problem affecting a significant number of the global population. The chances of urinary incontinence are associated with numerous factors such as the increasing rates of obesity; the growing geriatric population; rising prevalence of various chronic diseases, such as cardiovascular diseases, prostate cancer, kidney diseases, multiple sclerosis, diabetes, and stress-related incontinence due to changing lifestyles. According to the National Institutes of Health (2016), 617 million people globally are aged 65 and above.The elderly population is expected to grow significantly in Africa, followed by North America, Latin America and the Caribbean, and Asia Pacific. Urinary incontinence (UI) is a major and most common issue in the geriatric population associated with medical conditions, such as cerebral palsy, spinal cord injuries, multiple sclerosis, prostate enlargement, and cancer.The burden of urinary incontinence grows with the growing elderly population across the globe. According to a report published by the Centers for Disease Control and Prevention (CDC) 2014, nearly 44% of people aged 65 and above reported bladder incontinence in the US. Similarly, according to a report published by age UK in 2018, around 3.2 million people aged over 65 are suffering from urinary incontinence. Thus, the increasing prevalence of urinary incontinence propels the silicone based catheters market growth. The global silicone based catheters market, based on application, is segmented into urinary tract infection (UTI)/catheter acquired urinary tract infection (CAUTI), surgery on contiguous structures of the genitourinary tract, prostate gland surgery, spinal cord injury, and others.The urinary tract infection (UTI)/catheter acquired urinary tract infection (CAUTI) segment held the largest market share in 2021. However, the prostate gland surgery segment is anticipated to register the highest CAGR during the forecast period.The global silicone based catheters market, based on usage, is segmented into male, female, and pediatric. The female segment held the largest market share in 2021.Moreover, the same segment is anticipated to register the highest CAGR during 2021-2028. The global silicone based catheters market, based on tip, is bifurcated into Nelaton tip and Tiemann tip. The Nelaton tip segment held a larger market share in 2021. Moreover, the same segment is anticipated to register a higher CAGR during the forecast period. The global silicone based catheters market, based on product type, is segmented into short-term Foley catheters, long-term Foley catheters, and others. The short-term Foley catheters segment held the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period. The global silicone based catheters market, by type, is bifurcated into 2 way sizes: 6 to 26 Fr and 3 way sizes: 16 to 26 Fr. The 2 way sizes: 6 to 26 Fr segment held a larger market share in 2021. Moreover, the same segment is anticipated to register a higher CAGR during the forecast period. The global silicone based catheters market, based on end user, is segmented into hospitals, nursing homes and clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2021. COVID-19 pandemic negatively impacted the silicone based catheters market.Before the pandemic, the rate of hospitalization was growing continuously. The rising number of urological procedures and other conditions that require catheterization was supporting the silicone based catheters market before the pandemic. For instance, as published by Agency for Healthcare Research and Quality (AHRQ), the volume of ambulatory surgeries performed at US community hospitals was 19.2 million surgeries in 2018. The top 20 major ambulatory surgery categories constituted 10.0 million surgeries (64% of all major ambulatory surgeries) and accounted for 8.1 million major ambulatory surgery encounters. The increasing number of surgeries indicated the high demand for foley catheters that were being used during surgical procedures. However, the COVID-19 outbreak prompted institutions and governing bodies to postpone or cancel nonessential surgeries and procedures, which negatively impacted the overall healthcare system. As surgeries, diagnosis, and treatments were postponed during the pandemic, the overall catheters market was highly hampered. However, during the pandemic, self-catheterization was promoted and supported patient’s conditions in home care settings. Various organic and inorganic developments have been adopted by the companies in the silicone based catheters market.Many companies focus on organic strategies, such as product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships.These growth strategies have aided the market players in expanding their business, contributing toward the silicone based catheters market growth and enhancing their geographic presence. Additionally, growth strategies such as acquisitions and partnerships helped in strengthening their customer base and increasing the product portfolio. A few of the significant developments made by key players are listed below: In September 2019, ConvaTec Group Plc signed an agreement to purchase the assets of Southlake Medical Supplies, Inc., a Texas-based independent provider of catheter-related supplies. In March 2021, Bactiguard published, randomized, controlled multicenter study in India showed that urinary catheters with Bactiguard’s coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69 % compared to standard catheters. A few of the major primary and secondary sources referred to while preparing the report on the silicone based catheters market are the National Center for Health Statistics (a department of the US Department of Health & Human Services), Centers for Disease Control and Prevention (CDC), and Organization for Economic Co-operation and Development (OECD). Read the full report: https://www.reportlinker.com/p06270040/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

(Bloomberg) -- Bill Gates has a short position against Tesla Inc. that would now need between $1.5 billion and $2 billion to close out, Elon Musk said Friday in a series of tweets.Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff to SellRussian Wins in Eastern Ukraine Spark Debate Over Course of WarUkraine Latest: EU Leaders Talk t

Amazon's stock split will take place on June 3, but don't expect to wake up to riches overnight.

Stop investing in mediocre businesses. Buy the best, instead.

‘I have made an earnest attempt to get the bank to take their money back, so I was wondering if at any point or time the money would become legally mine.’

Real estate mogul Barbara Corcoran didn't mince words when asked about Tesla (TSLA) CEO Elon Musk's recent behavior.

(Bloomberg) -- The stock market has staged a ferocious rebound in the past week after almost falling into a bear market. Don’t get too excited about that, says Victoria Greene, founding partner and chief investment officer at G Squared Private Wealth.Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff to SellRussian Wins in Eastern U

Will we have enough to ‘live a simple life’ in retirement? Many other retirees wonder the same thing as you, and may be in similar financial circumstances where they’re able to pay the bills and have money saved in their retirement accounts. Your interest rate is fantastic, you’re capable of making the monthly payment from just your pension and Social Security without tapping into your 401(k) and you have so much of your home already paid off — all wins.

It’s difficult for most stocks to make any headway in 2022. Inflation, rising interest rates and Russia’s ongoing war on Ukraine have dragged down even those with minimal exposure to the macro headwinds. For Novavax (NVAX), these worries have been amplified by other considerations. First, there is the prospect of dwindling global demand for Covid-19 vaccines, what with the virus on the backfoot in many parts of the world and there being an oversupply in selected regions. Secondly, in the U.S. at

These rapidly growing stocks are begging to be bought following a more than 30% peak decline in the Nasdaq.

The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.

The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.

Don't make the same mistake as Zillow when you try to price a home.

The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.

When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.

Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh

Markets are shaky. Your income stream doesn’t have to be.

Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.

The stock market ended its multiweek losing streak, and like a sports team that finally got a win, it’s worth celebrating. It just doesn’t mean the team—or this stock market—is any good. “Stocks finally enjoyed a strong bounce this week,” writes Canaccord Genuity analyst Martin Roberge.

The company does not have a long history of payouts, but it has the qualities of an excellent dividend stock.

The top-ranked companies on dividend payout ratios outperformed those stocks with less robust buyback activity—10.9% versus 9.3% on an annual basis over the 20-year period that concluded at the end of 2019.